Share Twitter LinkedIn Facebook Email Habte Yimer, M.D. Chairman, Hematology/Oncology Department, CHRISTUS Trinity Mother Frances Hospital, Medical Oncology Specialist in Tyler, TX Discusses Lyra: Front Line, First Relapse Study For MM At The 60th ASH Annual Meeting on Dec 1, 2018.
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read